NUBL Nirdhan Utthan Laghubitta Bittiya Sanstha Limited
Nirdhan Utthan Laghubitta Bittiya Sanstha Limited (NUBL) is listed on the Nepal Stock Exchange in the Microfinance sector. Its share price is Rs 607.00 as of 6 November 2026, 24.3% below its 52-week high of Rs 802.00 and 9.3% above its 52-week low of Rs 555.10. It trades at a P/E of 47.4 on earnings per share of Rs 12.80, more expensive than the Microfinance sector's median P/E of 32.6.
NUBL paid a dividend in 6 of the last 8 fiscal years we track; the latest was 7.00% cash and 5.00% bonus for FY 2081/2082. Promoters hold 51% of the shares and the public 49%.
Key figures latest report 2082/2083 Q4
Quarter by quarter trailing 12 months at each quarter
| Quarter | EPS | EPS growth (y/y) | Net profit | Revenue | ROE |
|---|---|---|---|---|---|
| 2082/2083 Q4 | 68.71 | +125.4% | 188.46 crore · 1.88 arba | 367.90 crore · 3.68 arba | 32.1% |
| 2082/2083 Q3 | 18.61 | -37.1% | 51.05 crore | 371.44 crore · 3.71 arba | 8.9% |
| 2082/2083 Q2 | 29.89 | +32.9% | 81.98 crore | 359.73 crore · 3.60 arba | 14.7% |
| 2082/2083 Q1 | 35.80 | +55.9% | 98.18 crore | 338.92 crore · 3.39 arba | 18.0% |
| 2081/2082 Q4 | 30.48 | +65.1% | 83.61 crore | 356.00 crore · 3.56 arba | 15.7% |
| 2081/2082 Q3 | 29.58 | +510.5% | 81.12 crore | 350.60 crore · 3.51 arba | 15.8% |
| 2081/2082 Q2 | 22.49 | 0.0% | 61.69 crore | 364.60 crore · 3.65 arba | 12.4% |
| 2081/2082 Q1 | 22.97 | 0.0% | 62.99 crore | 387.84 crore · 3.88 arba | 13.1% |
Dividends
| Fiscal year | Bonus | Cash | Book close |
|---|---|---|---|
| 2081/2082 | 5.00% | 7.00% | 1 Jan 2026 |
| 2080/2081 | – | – | – |
| 2079/2080 | – | – | – |
| 2078/2079 | 19.00% | 1.00% | 14 Feb 2023 |
| 2077/2078 | 29.50% | 1.55% | 28 Dec 2021 |
| 2076/2077 | 13.00% | 0.68% | 23 Feb 2021 |
| 2075/2076 | 25.00% | 15.53% | 16 Dec 2019 |
| 2074/2075 | 20.00% | 22.11% | 27 Nov 2018 |
Bonus / right shares: Jan 2026 Bonus share 5% · Feb 2023 Bonus share 19% · Dec 2021 Bonus share 29.5%
Who owns it
- Public float
- 13,439,150 shares
- Mutual funds hold
- 11.4% of the float
- Promoter lock-in
- –
Latest news
- 6 Nov Nirdhan Utthan Laghubitta Bittiya Sanstha Limited has posted a net profit of Rs 115.46 million and published its 1st quarter company analysis of the fiscal year 2083/84.
MacroLens analysis of NUBL
Other Microfinance companies
| Company | Price | Today | P/E | P/B | Market value |
|---|---|---|---|---|---|
| SKBBL Sana Kisan Bikas Laghubitta Bi... | 762.00 | +0.26% | 51.1 | 3.38 | 3,755 crore · 37.55 arba |
| CBBL Chhimek Laghubitta Bittiya San... | 987.00 | -0.28% | 27.5 | 3.93 | 3,570 crore · 35.70 arba |
| JBLB Jeevan Bikas Laghubitta Bittiy... | 1,289.00 | +0.62% | 20.9 | 4.60 | 2,257 crore · 22.57 arba |
| NMFBS National Laghubitta Bittiya Sa... | 1,192.40 | +0.54% | 20.4 | 4.27 | 1,814 crore · 18.14 arba |
| DDBL Deprosc Laghubitta Bittiya San... | 862.50 | -0.52% | 17.9 | 3.80 | 1,773 crore · 17.73 arba |
| SWBBL Swabalamban Laghubitta Bittiya... | 724.00 | 0.00% | 20.4 | 2.99 | 1,267 crore · 12.67 arba |
| FOWAD Forward Microfinance Laghubitt... | 900.10 | +0.57% | 17.3 | 3.23 | 1,076 crore · 10.76 arba |
| FMDBL First Micro Finance Laghubitta... | 718.00 | +0.28% | 135.7 | 5.15 | 965.62 crore · 9.66 arba |
Every Microfinance company 49
Browse all NEPSE stocks by sector →
NUBL: common questions
What is the share price of NUBL today?
NUBL (Nirdhan Utthan Laghubitta Bittiya Sanstha Limited) closed at Rs 607.00 as of 6 November 2026 on NEPSE.
Does NUBL pay dividends?
NUBL paid a dividend in 6 of the last 8 fiscal years we track; the latest was 7.00% cash and 5.00% bonus for FY 2081/2082.
What is the P/E ratio of NUBL?
It trades at a P/E of 47.4 on earnings per share of Rs 12.80, more expensive than the Microfinance sector's median P/E of 32.6.
Is NUBL a good buy?
This page is not buy or sell advice. MacroLens NP rates every NEPSE company on its fundamentals - NUBL's rating, fair value, dump risk and broker activity are on the desk, free for 7 days.
Prices from NEPSE; figures from the company's quarterly reports; dividends, ownership and news from public filings. Research, not a recommendation to buy or sell - see the risk disclosure.